DR info

Clinical trials : 72 / Drugs : 53 - (DrugBank : 16) / Drug target genes : 19 - Drug target pathways : 35

Porphyria and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
254	Porphyria
2	Amyotrophic lateral sclerosis
6	Parkinson disease
13	Multiple sclerosis/Neuromyelitis optica
5	Progressive supranuclear palsy
226	Interstitial cystitis with Hunners ulcer
8	Huntington disease
86	Pulmonary arterial hypertension
98	Eosinophilic gastrointestinal disease
323	Aromatic L-amino acid decarboxylase deficiency
156	Rett syndrome
299	Cystic fibrosis
46	Malignant rheumatoid arthritis
26	HTLV-1-associated myelopathy
296	Biliary atresia
21	Mitochondrial disease
206	Fragile X syndrome
53	Sjogren syndrome
17	Multiple system atrophy
70	Spinal stenosis
19	Lysosomal storage disease
4	Primary lateral sclerosis
212	Tricuspid atresia
118	Myelomeningocele
187	Kabuki syndrome
169	Menkes disease
170	Occipital horn syndrome
11	Myasthenia gravis
140	Dorabe syndrome
90	Retinitis pigmentosa
107	Juvenile idiopathic arthritis
280	Huge arteriovenous malformation with cervicofacial or limb lesion